Halper Sadeh LLC Investigates Apellis Pharmaceuticals Acquisition

Lawsuit alleges Apellis may not be obtaining best deal for shareholders in potential acquisition.

Mar. 31, 2026 at 1:43pm

Got story updates? Submit your updates here. ›

A minimalist studio still life featuring a stack of pharmaceutical pill bottles and vials arranged elegantly on a clean, monochromatic background, conceptually representing the high-stakes corporate negotiations and legal scrutiny surrounding a potential acquisition.A legal investigation into a potential pharmaceutical acquisition raises questions about corporate transparency and shareholder value.NYC Today

Halper Sadeh LLC, a national shareholder rights litigation firm, has launched an investigation into whether Apellis Pharmaceuticals, Inc. is obtaining the best possible deal for its shareholders in a potential acquisition. The investigation focuses on the financial and other potential benefits to Apellis' board of directors.

Why it matters

Apellis Pharmaceuticals is a major biopharmaceutical company, and any potential acquisition could have significant implications for the industry and its shareholders. Halper Sadeh's investigation aims to ensure that Apellis is acting in the best interests of its shareholders throughout the process.

The details

Halper Sadeh LLC is investigating whether Apellis Pharmaceuticals' board of directors is fulfilling its fiduciary duties to its shareholders in evaluating a potential sale of the company. The investigation will focus on the proposed transaction's financial terms and the process leading up to any potential deal.

  • Halper Sadeh LLC launched its investigation on March 31, 2026.

The players

Halper Sadeh LLC

A national shareholder rights litigation firm that specializes in investigating potential breaches of fiduciary duty by corporate boards of directors.

Apellis Pharmaceuticals, Inc.

A major biopharmaceutical company that is the subject of Halper Sadeh's investigation regarding a potential acquisition.

Got photos? Submit your photos here. ›

What they’re saying

“We are investigating the proposed transaction to determine if the board of directors of Apellis Pharmaceuticals is acting in the best interests of Apellis shareholders.”

— Daniel Sadeh, Partner, Halper Sadeh LLC

What’s next

Halper Sadeh LLC will continue its investigation and may take further legal action if it determines that Apellis Pharmaceuticals is not obtaining the best possible deal for its shareholders.

The takeaway

This investigation highlights the importance of corporate boards fulfilling their fiduciary duties to shareholders, especially in the context of potential mergers and acquisitions that could significantly impact a company's value.